LKB1 reduces ROS-mediated cell damage via activation of p38.

Xu, H. G.,Zhai, Y. X.,Chen, J.,Lu, Y.,Wang, J. W.,Quan, C. S.,Zhao, R. X.,Xiao, X.,He, Q.,Werle, K. D.,Kim, H. G.,Lopez, R.,Cui, R.,Liang, J.,Li, Y. L.,Xu, Z. X.; Oncogene. 2014 Sep 30.

Inhibiting inhibitory pathways in human γδ T cells.

Lopez, R. D.; Blood. 2013 Aug 10.

Alemtuzumab for the prevention and treatment of graft-versus-host disease.

January, C.T., Makielski, J.C., Duff, H.; Int J Hematol. 2011 May.